Product image of Omezalin (Omeprazole) supplied by GNH India

Omezalin

Active Ingredient:
Omeprazole
Origin:
EU

Omezalin (Omeprazole)

Omeprazole, the active ingredient in Omezalin, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat gastro‑intestinal reflux disease and ulcers in adults and children.
GNH India supplies Omezalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pharma Therapis Single Member Pc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Omezalin is a proton pump inhibitor that acts on the acid‑secretion pathway in the stomach. It is indicated for several gastrointestinal conditions:

  • Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining.
  • Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
  • Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the disorder.

How It Works

  • Omeprazole irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells, blocking the final step of acid production. This inhibition markedly lowers gastric acidity, allowing mucosal healing and symptom relief.

Side Effects

Adverse reactions to Omezalin are generally mild to moderate and vary with duration of therapy.

Common Side Effects

  • Headache: mild, transient headache.
  • Diarrhea: loose stools without blood.
  • Nausea: occasional feeling of queasiness.
  • Abdominal pain: mild discomfort in the stomach area.
  • Flatulence: increased intestinal gas.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
  • Acute interstitial nephritis: kidney inflammation with reduced urine output.
  • Hypomagnesemia: low serum magnesium causing muscle cramps.
  • Stevens‑Johnson syndrome: severe skin rash and mucosal involvement.
  • Liver enzyme elevation: increased ALT/AST levels indicating hepatic stress.

Precautions & Warnings

When prescribing Omezalin, clinicians should consider several safety aspects:

  • Renal impairment: adjust monitoring if kidney function is reduced.
  • Hepatic impairment: use with caution in patients with liver disease.
  • Long‑term use: assess need for periodic vitamin B12 monitoring.
  • Drug‑induced osteoporosis risk: evaluate calcium and vitamin D status during extended therapy.
  • Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed.
  • Store at ambient temperature: keep below 25 °C, retain original packaging, and protect from moisture.

Avoid Interactions

Omeprazole may affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effect, increasing cardiovascular event risk.
  • Atazanavir: decreased antiviral exposure, compromising HIV therapy.
  • Methotrexate: heightened toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely)

  • Warfarin: potential INR elevation; monitor coagulation parameters.
  • Digoxin: possible increase in serum levels; check cardiac status.
  • Phenytoin: altered metabolism may change seizure control.
  • Ketoconazole: reduced antifungal absorption; consider alternative agents.

Frequently Asked Questions

Omezalin contains omeprazole, a proton pump inhibitor that is prescribed for gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome. It works by lowering stomach acid, which helps relieve symptoms and promotes healing of the gastrointestinal lining.

Omeprazole irreversibly inhibits the gastric H+/K+‑ATPase pump in parietal cells, blocking the final step of acid secretion. This reduction in gastric acidity creates a less hostile environment for the oesophageal and gastric mucosa, allowing lesions to heal and symptoms to improve.

The appropriate dose of Omezalin is determined by the prescribing clinician based on the specific indication, patient age, renal and hepatic function, and treatment duration. Dosage regimens are individualized and should follow the prescriber’s instructions.

Omeprazole is classified as pregnancy category B in many regions, indicating no proven risk in animal studies but limited human data. It may be used during pregnancy or lactation only when clearly needed, and the prescriber should evaluate the risk‑benefit balance for mother and infant.

To request Omezalin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Omezalin (omeprazole) belongs to the proton pump inhibitor class, offering more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with newer PPI agents, omeprazole has a well‑established efficacy and safety profile, though individual response may vary.

Store Omezalin tablets at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Omezalin is taken orally, usually as a whole tablet with a glass of water. It is commonly recommended to swallow the tablet before a meal, although specific timing should follow the prescriber’s guidance.

Serious adverse reactions, though rare, can include Clostridioides difficile‑associated colitis, acute interstitial nephritis, severe hypersensitivity reactions such as Stevens‑Johnson syndrome, and significant electrolyte disturbances like hypomagnesemia. Patients should seek immediate medical attention if they experience severe diarrhea, rash, or kidney‑related symptoms.

Individuals with known hypersensitivity to omeprazole or any component of the tablet formulation should avoid Omezalin. Caution is also advised for patients with severe liver disease, and it should not be used in conjunction with drugs that have major interaction risks unless closely monitored.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Omeprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT